Results 151 to 160 of about 13,346 (214)

Factors Influencing Immunotherapy Response in Neuroblastoma: From Tumor Microenvironment to Combination Strategies. [PDF]

Cells
Du X, Dong R, Dong K.
europepmc   +1 more source

Protocol for intracardiac delivery and live imaging of NK-tumor interactions in an ex ovo chick embryo model. [PDF]

STAR Protoc
Saari M, Järvelä E, Ali T, Siddiqui H, Göös H, Korhonen M, Schenkwein D, Ylä-Herttuala S, Vainio S, Skovorodkin I, Jahan F.   +10 more
europepmc   +1 more source

B7-H3 and GD2 overexpression as immunotherapeutic targets in retinoblastoma. [PDF]

Sci Rep
Sujjitjoon J, Ng WL, Kongkla K, Jarutatsanangkoon K, Chongsutakawewong K, Subhadhirasakul S, Uiprasertkul M, Udompunturak S, Junking M, Yenchitsomanus PT, Atchaneeyasakul LO.   +10 more
europepmc   +1 more source

Concurrent naxitamab and lorlatinib in a patient with refractory high-risk neuroblastoma: a case report. [PDF]

Front Oncol
Aydin S, Oz A.
europepmc   +1 more source

The gamma delta T/NK cell product GADEKILL as a novel immunotherapeutic tool for neuroblastoma patients: role of B7H6 and BTN2A1 in tumor cell killing. [PDF]

Front Immunol
Morandi F, Della Lastra M, Pastorino F, Ciampi E, Faraci M, Brignole C, Giardino S, Airoldi I.   +7 more
europepmc   +1 more source

De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell function. [PDF]

Nat Cancer
Bessler N, Wezenaar AKL, Ariese HCR, Honhoff C, Dommann N, Wehrens EJ, Ruiz Moreno C, van den Broek TJM, Collot RVU, Kloosterman DJ, Keramati F, Roosen M, de Blank S, van Vliet E, Barrera Román M, Gatti LCDE, Ertürk A, Kuball J, Sebestyén Z, Kool M, Patrizi S, Miele E, Künkele A, Kranendonk MEG, Cornel AM, Nierkens S, Mayer C, Stunnenberg HG, Alemany A, Alieva M, Rios AC.   +30 more
europepmc   +1 more source

A characterisation of the immune cells in immunocompetent and immunodeficient mice with orthotopic brain tumors. [PDF]

Clin Transl Immunology
Gardam B, Nam E, Kollis PM, Kilyen-Coles J, Lenin S, Gliddon BL, Tea MN, Pitson SM, Brown MP, Ebert LM, Gargett T.   +10 more
europepmc   +1 more source

Immunogenicity and Efficacy of a Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Against HSV-1 Eye Infection and Neuroinvasion in Mice. [PDF]

Vaccines (Basel)
Chalmin Katz A, Egan KP, Syeda Z, Son S, Watson B, Gopalakrishnan M, Bromberg V, Radaelli E, Assenmacher CA, Awasthi S, Cohen GH, Friedman HM.   +11 more
europepmc   +1 more source

The safety and efficacy of GD2-targeted CAR-T cells in patients with neuroblastoma: a systematic review and meta-analysis. [PDF]

Eur J Med Res
Habibi MA, Zand A, Robat-Jazi B, Khodadadiyan A, Dashti M, Nejati N, Lorestan P, Karimizadeh Z, Ahmadpour M, Maleki F, Ahmadpour S.   +10 more
europepmc   +1 more source

Fe-doping-driven enhancement of electronic conductivity and electrocatalytic performance in Gd₂O₃ nanoparticles for ultrasensitive electrochemical detection of chloramphenicol in pharmaceutical and milk samples. [PDF]

RSC Adv
Nguyen TA, An Nguyen NH, Dinh NX, Thanh Tam LT, Quang NX, Lu LT, Phan MH, Le AT.   +7 more
europepmc   +1 more source